id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-288552-7lp07v5i	Vahedi, Ensieh	The clinical value of two combination regimens in the Management of Patients Suffering from Covid-19 pneumonia: a single centered, retrospective, observational study	2020-06-19		.txt	text/plain	4914	232	40	CONCLUSION: This study revealed the beneficial effect of the short-term use of low-dose prednisolone in combination with azithromycin, naproxen and lopinavir/ritonavir (regimen I), in decreasing ALOS compared to regimen II. Therefore, the present study aimed to evaluate short-term effects of regimen I (azithromycin, prednisolone, naproxen, and lopinavir/ritonavir) in group I patients in comparison to regimen II (meropenem, levofloxacin, vancomycin, hydroxychloroquine, and oseltamivir) in group II patients in the treatment of COVID-19 infection. The patients' medical information including demographic data, COVID-19 test using a real-time RT-PCR via throatswab specimens, clinical features, routine laboratory tests, chest CT scans (before and after discharge) according to the WHO interim guidance [23] , treatment measures, comorbidities and data on the outcomes were extracted independently by two physicians through a standard case record form provided by the hospital.	./cache/cord-288552-7lp07v5i.txt	./txt/cord-288552-7lp07v5i.txt